Department of Breast Surgery, Aga Khan University Hospital Karachi, Pakistan.
Department of Breast Surgery, Aga Khan University Hospital, Karachi, Pakistan.
J Pak Med Assoc. 2023 Feb;73(Suppl 1)(2):S47-S55. doi: 10.47391/JPMA.AKUS-08.
Breast Cancer Stem Cells (BCSCs), unlike normal breast cells, exhibit the potential for self-regeneration and tumour formation and express unique markers. Studies have highlighted their role in tumour progression, recurrence, and treatment resistance. BCSCs can be one of the reasons that resistance is encountered despite recent advances in the treatment of breast cancer (BC). This review underlines the clinical implications at the molecular level of different cellular pathways, cellular level interactions in Tumour Micro Environment (TME), and types of markers and receptors involved in tumorigenesis. It accentuates the importance of comprehensive targeted treatment options available for BCSCs so that targeted modalities can be introduced to deal with treatment resistance. Stem cells (SCs) are a developing field, and limited data is available from our country to use stem cell-targeted treatment plans as a therapeutic option. Therefore, this literature review will provide insight for future research in this domain.
乳腺癌干细胞(BCSCs)与正常乳腺细胞不同,具有自我更新和肿瘤形成的潜力,并表达独特的标志物。研究强调了它们在肿瘤进展、复发和治疗耐药性中的作用。尽管乳腺癌(BC)的治疗最近取得了进展,但 BCSCs 可能是耐药性的原因之一。本综述强调了不同细胞通路在分子水平、肿瘤微环境(TME)中的细胞水平相互作用以及参与肿瘤发生的标记物和受体类型的临床意义。它强调了针对 BCSCs 的综合靶向治疗方案的重要性,以便引入靶向治疗方式来应对治疗耐药性。干细胞(SCs)是一个不断发展的领域,我们国家可用的关于干细胞靶向治疗计划作为治疗选择的相关数据有限。因此,本文献综述将为该领域的未来研究提供参考。